Invivyd, Inc.
A biopharmaceutical company making monoclonal antibody medicines for viral diseases, Invivyd's only commercial product is PEMGARDA (pemivibart), a preventive antibody given to certain immunocompromised adults and teens at risk of COVID-19. It was founded in 2020 as Adagio Therapeutics, a spin-out of the antibody-discovery firm Adimab, and renamed Invivyd in 2022. The name hints at its mission of building antibodies that outpace fast-mutating viruses.
Granted 165.0K · Sold 67.7K
Granted 99.0K · Sold 40.6K
Granted 99.0K · Sold 37.6K
Granted 99.0K · Sold 40.6K
Granted 99.0K · Sold 40.6K
Bought 50.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Andersen JillChief Legal Officer, Secretary · 3 transactions | +114.5% | 182.2K | 165.0K | — | 67.7K |
| Lee Timothy EdwardChief Commercial Officer · 3 transactions | +98.4% | 117.7K | 99.0K | — | 40.6K |
| Allen Robert D. IIIChief Scientific Officer · 3 transactions | +115.7% | 114.5K | 99.0K | — | 37.6K |
| Duke William E.Chief Financial Officer · 3 transactions | +118.3% | 107.7K | 99.0K | — | 40.6K |
| Green JulieChief Human Resources Officer · 3 transactions | +118.3% | 107.7K | 99.0K | — | 40.6K |
| McLaughlin Kevin FDirector · 1 transaction | — | 50.0K | — | 50.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -177.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.